
Wörwag R&D GmbH as affiliate of Wörwag Pharma has a focus on dossier development, registration and outlicensing of generic / OTC drugs, predominantly antidiabetic, cardiovascular and CNS products.
Core Sales Territory: Global Regulated Markets
Core Operation: Sales and Marketing
Number of molecules sold: 15
If you cannot find the product you are looking for, please ask the developer via the 'make enquiry' button
Clients in focus...
Book your consultation slot now!
Simply contact us to discuss advertising or partnership agreement.